Lineage Cell Therapeutics Inc (LCTX) earnings · rev $14.6M
These earnings events as JSON? API free 100/dayLineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
This LCTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LCTX revenue for 2025-12-31 was $14.6M. Net income was -$63.5M. Revenue was up 53.2% from 2024-12-31 to 2025-12-31. LCTX currently screens at market cap $213.6M.
When the next LCTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 53.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LCTX research stays on the stock page; the tape stays on the quote page.
LCTX earnings FAQ
What are LCTX's latest revenue and net income?
Latest cached Lineage Cell Therapeutics Inc (LCTX) revenue for Dec 31, 2025 was $14.6M. Net income was -$63.5M. Statements: https://lician.com/financials/lctx
What is LCTX's latest diluted EPS?
Latest cached Lineage Cell Therapeutics Inc (LCTX) diluted EPS for Dec 31, 2025 was -$0.28.
What period does the latest LCTX earnings print cover?
The latest cached Lineage Cell Therapeutics Inc (LCTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did LCTX revenue change from the prior cached period?
Cached Lineage Cell Therapeutics Inc (LCTX) revenue was up 53.2% from $9.5M (Dec 31, 2024) to $14.6M (Dec 31, 2025). Statements: https://lician.com/financials/lctx
Where are LCTX earnings listed?
Cached earnings facts for Lineage Cell Therapeutics Inc (LCTX) are listed at https://lician.com/earnings/lctx. Statements: https://lician.com/financials/lctx
Not investment advice.